Ayrton Drug Manufacturing Ltd. announced unaudited earnings results for the first quarter ended Sep. 30, 2017. For the quarter, the company reported revenue of GHS 9,003,091 against GHS 9,132,709 a year ago. Operating Profit was GHS 1,646,745 against GHS 1,337,559 a year ago. Profit before taxation was GHS 1,223,603 against GHS 995,483 a year ago. Profit after tax was GHS 936,208 against GHS 696,454 a year ago. Earnings per share were GHS 0.0044 against GHS 0.0032 a year ago. Net cash flow from operating activities was GHS 485,124 against GHS 547,532.97 a year ago. Cash used in purchase of property, plant and equipment was GHS 30,769 against GHS 220,260 a year ago.